| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 06/21/2007 | US20070141699 Methods of using the signal to transmit and maintain influenza viral and foreign nucleic acid in virus and cells; hemagglutinin (HA) and neuraminidase (NA). |
| 06/21/2007 | US20070141698 Microbial protein expression system utilizing plant viral coat protein |
| 06/21/2007 | US20070141685 Feedback-resistant mevalonate kinases |
| 06/21/2007 | US20070141677 Genetic immunization with cationic lipids |
| 06/21/2007 | US20070141676 Cytokine protein family |
| 06/21/2007 | US20070141675 Process for producing glycoprotein |
| 06/21/2007 | US20070141674 Host cells and culture methods |
| 06/21/2007 | US20070141673 Tool for quantitative real-time analysis of viral gene expression dynamics in single living cells |
| 06/21/2007 | US20070141672 Minimalist bZIP Proteins and uses thereof |
| 06/21/2007 | US20070141671 canine interleukin -5 protein for use in identifying immunomodulators which treat or prevent autoimmune, allergic, infectious, inflammatory and graft rejection disorders in animals |
| 06/21/2007 | US20070141670 Mammalian cytokine-like polypeptide-10 |
| 06/21/2007 | US20070141669 Pregnancy-associated plasma protein-A2 (PAPP-A2) |
| 06/21/2007 | US20070141668 Cloned genome of infectious hepatitis C virus of genotype 2A and uses thereof |
| 06/21/2007 | US20070141667 Biopolymer based on lactococcus lactis nrrl b-60656, process for culturing lactocuccus lactis nrrl b-30656, and process for preparing the biopolymer |
| 06/21/2007 | US20070141666 Leader sequences for use in production of proteins |
| 06/21/2007 | US20070141665 Chimeric protein for the screening of agonists and antagonists of cell signalling pathways that are dependent on g-protein-coupled receptors |
| 06/21/2007 | US20070141664 Csnks as modifiers of the rac pathway and methods of use |
| 06/21/2007 | US20070141663 Process for the preparation of copolymer-1 |
| 06/21/2007 | US20070141662 Fusion proteins and methods of cleavage of such proteins |
| 06/21/2007 | US20070141661 Cell extract for high-functioned cell-free protein synthesis and method of preparing the extract |
| 06/21/2007 | US20070141648 Flj10607 as modifier of the axin pathway and methods of use |
| 06/21/2007 | US20070141643 Protease inhibitor conjugates and antibodies useful in immunoassay |
| 06/21/2007 | US20070141640 a polynucleotide comprising a nucleotide sequence that codes for a sodium channel protein having an amino acid sequence in which one or more amino acids differs from the amino acids in the wild-type protein by replacements, used for screening compounds for use as antiarrhythmic agents |
| 06/21/2007 | US20070141634 Assay |
| 06/21/2007 | US20070141619 Drug resistance-associated gene and use thereof |
| 06/21/2007 | US20070141609 Screening and Therapy for Lymphatic Disorders Involving the FLT4 Receptor Tyrosine Kinase (VEGFR-3) |
| 06/21/2007 | US20070141608 Nucleotide sequences coding polypeptide for use ias diagnostic tool in genetic engineering; proteins that are colored and/or fluorescent, where this feature arises from the interaction of two or more residues of the protein |
| 06/21/2007 | US20070141607 Nucleotide sequences coding polypeptide for use ias diagnostic tool in genetic engineering; proteins that are colored and/or fluorescent, where this feature arises from the interaction of two or more residues of the protein |
| 06/21/2007 | US20070141606 Nucleotide sequences coding polypeptide for use ias diagnostic tool in genetic engineering; proteins that are colored and/or fluorescent, where this feature arises from the interaction of two or more residues of the protein |
| 06/21/2007 | US20070141603 Tumor necrosis factor; isolating protein from cell culture; use in drug discovery screens compounds that block synthesis |
| 06/21/2007 | US20070141600 ME-5, ME-2, and EPP2: human protein antigens reactive with autoantibodies present in the serum of women suffering from endometriosis |
| 06/21/2007 | US20070141592 Thermostable reverse transcriptases and uses thereof |
| 06/21/2007 | US20070141590 Modulators of tissue regeneration |
| 06/21/2007 | US20070141579 MUM-1 protein expressed by multiple myeloma-related gene |
| 06/21/2007 | US20070141578 LuxO-sigma54 interactions and methods of use |
| 06/21/2007 | US20070141573 Complement inhibitors |
| 06/21/2007 | US20070141569 Splice variant of human placental growth hormone |
| 06/21/2007 | US20070141566 Methods and materials relating to novel polypeptides and polynucleotides |
| 06/21/2007 | US20070141557 Method and device for optimizing a nucleotide sequence for the purpose of expression of a protein |
| 06/21/2007 | US20070141087 Compounds and methods for diagnosis of tuberculosis |
| 06/21/2007 | US20070141085 Recombinant protective protein from Streptococcus pneumoniae |
| 06/21/2007 | US20070141075 Plasmodium vivax blood stage antigens, PVESP-1, antibodies and diagnostic assays |
| 06/21/2007 | US20070141072 Use of multifunctional transcription factor yin-yang-1 and variants thereof for treating illnesses, especially type 1 diabetes |
| 06/21/2007 | US20070141070 Methods and compositions for needleless delivery of antibodies |
| 06/21/2007 | US20070141065 capable of binding to mouse Vascular endothelial cell growth factor (VEGF) and human VEGF; cancer, diabetes related diseases, edema, inflammation |
| 06/21/2007 | US20070141064 Fully human hybridoma fusion partner cell lines |
| 06/21/2007 | US20070141063 Peptide having ability to activate cancer-related gene |
| 06/21/2007 | US20070141047 Feline immunoglobulin e proteins and compositions thereof |
| 06/21/2007 | US20070141040 Protein kinase C peptide modulators of angiogenesis |
| 06/21/2007 | US20070141024 Mammalian cytokine; reagents and methods |
| 06/21/2007 | US20070140989 Protein with activity of hydrolyzing dextran, starch, mutan, inulin and levan, gene encoding the same, cell expressing the same, and production method thereof |
| 06/21/2007 | CA2631491A1 Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides |
| 06/21/2007 | CA2630811A1 Improved production of glycoproteins using manganese |
| 06/21/2007 | CA2604928A1 Methods for obtaining optically active epoxides and diols from 2,3-disubstituted and 2,3-trisubstituted epoxides |
| 06/20/2007 | EP1798288A2 Human Toll-like receptor proteins, related reagents and methods |
| 06/20/2007 | EP1798243A2 Ganglioside-associated recombinant antibodies and the use thereof in the diagnosis and treatment of tumors |
| 06/20/2007 | EP1798242A2 New anti-GF-IR antibodies and their applications |
| 06/20/2007 | EP1798239A2 G-protein coupled receptors and uses therefor |
| 06/20/2007 | EP1797430A2 Methods and compositions for the diagnosis and treatment of cancer |
| 06/20/2007 | EP1797427A2 Methods for identifying new drug leads and new therapeutic uses for known drugs |
| 06/20/2007 | EP1797199A2 Cardiac pressure overload associated genes |
| 06/20/2007 | EP1797193A2 Increasing hemoglobin and other heme protein production in bacteria by co-expression of heme transport genes |
| 06/20/2007 | EP1797192A1 Modified proteins |
| 06/20/2007 | EP1797187A2 Methods and compositions for concentrating secreted recombinant protein |
| 06/20/2007 | EP1797186A1 Expression system, components thereof and methods of use |
| 06/20/2007 | EP1797177A2 Adding photoregulated amino acids to the genetic code |
| 06/20/2007 | EP1797117A2 Cloning and expression of recombinant adhesive protein mefp-1 of the blue mussel, mytilus edulis |
| 06/20/2007 | EP1436331B1 Process for the production of egg yolk antibodies against organochlorine pesticides |
| 06/20/2007 | EP1427821B1 Biosensor for small molecule analytes |
| 06/20/2007 | EP1358353B1 Identification of genetic determinants of polymorphic cyp3a5 expression |
| 06/20/2007 | EP1179010B1 Previns as specific inhibitors and therapeutic agents for botulinum toxin b and tetanus neurotoxins |
| 06/20/2007 | EP1124946B1 Glycosylated proteins having reduced allergenicity |
| 06/20/2007 | EP0745121B1 Mutated steroid hormone receptors, methods for their use and molecular switch for gene therapy |
| 06/20/2007 | CN1985000A T-cell death-inducing epitopes |
| 06/20/2007 | CN1984999A Tolerance-induced targeted antibody production |
| 06/20/2007 | CN1984678A Immunogenic compositions for pneumonia chlamydia |
| 06/20/2007 | CN1984677A Truncated hepatitis C virus NS5 domain and fusion proteins comprising same |
| 06/20/2007 | CN1982468A Preparation of shrimp peptide powder |
| 06/20/2007 | CN1982459A Method of preparing mammal cell kinetin synthesis inhibitoroy factor |
| 06/20/2007 | CN1982336A Human pancreas glucagon sample peptide-1-derivative, its production and use |
| 06/20/2007 | CN1982331A Recombinant thymus pentapeptide structural analogs, its production and use |
| 06/20/2007 | CN1982330A Methods for preparing purified lipopeptides |
| 06/20/2007 | CN1982324A Oncogene, recombinant protein derived therefrom, and uses thereof |
| 06/20/2007 | CN1322134C Expression system |
| 06/20/2007 | CN1322128C MIP gene clone, recombination, expression and protein purifying method for Legionlla pneumophila |
| 06/20/2007 | CN1322127C BASB029 polynucleotide(s) and polypeptides from i(neisseria meningitidis) |
| 06/20/2007 | CN1322124C Gene of coding cobweb protein and use thereof |
| 06/20/2007 | CN1322121C Hyaluronan synthase gene and uses thereof |
| 06/20/2007 | CN1322118C Mononal antibody against avermectin, hybridoma cell line secreting the same and its preparation method |
| 06/20/2007 | CN1322008C Monoclonal antibody of anti lymphocyst virus of and preparation method |
| 06/20/2007 | CN1322007C Antibacterial peptide DC and its preparing process and use |
| 06/20/2007 | CN1322003C Methods of producing target molecule in transgenic animal and purification of target molecule |
| 06/20/2007 | CN1321693C Over-expressing homologous antigen vaccine and method of making same |
| 06/20/2007 | CN1321685C Peptidoglycan immunopotentiator and its production process |
| 06/19/2007 | USRE39696 Human cyclooxygenase-2 cDNA and assays for evaluating cyclooxygenase-2 activity |
| 06/19/2007 | US7232940 Moderation of gene expression in plants; transformed cell |
| 06/19/2007 | US7232899 Targeted plasmids comprising viral tripartite leader (TPL) sequences for facilitating development of high capacity gene therapy/transfer tools |
| 06/19/2007 | US7232893 Producing conditioned media from an immortalized hepatocyte, applying the conditioned media to at least one column, and collecting fractions containing a stellate cell death factor wherein the stellate cell death factor is capable of activating caspase 7 in a liver stellate cell |
| 06/19/2007 | US7232892 Antibodies to a polypeptide encoded by a nucleic acid differentailly expressed in stomach, lung and melanoma tumor |
| 06/19/2007 | US7232890 Diagnosis, therapy of breast cancer; adjustment of gene expression |